646 related articles for article (PubMed ID: 26287242)
1. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin for the Treatment of Neuropathic Pain.
Park J; Park HJ
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin Treatment of Neuropathic Pain.
Mittal SO; Safarpour D; Jabbari B
Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin for neuropathic pain and spasticity: an overview.
Brown EA; Schütz SG; Simpson DM
Pain Manag; 2014 Mar; 4(2):129-51. PubMed ID: 24641437
[TBL] [Abstract][Full Text] [Related]
5. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
Bagues A; Hu J; Alshanqiti I; Chung MK
Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
[TBL] [Abstract][Full Text] [Related]
6. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
Halb L; Amann BJ; Bornemann-Cimenti H
Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
[TBL] [Abstract][Full Text] [Related]
7. Do botulinum toxins have a role in the management of neuropathic pain?: a focused review.
Francisco GE; Tan H; Green M
Am J Phys Med Rehabil; 2012 Oct; 91(10):899-909. PubMed ID: 22660369
[TBL] [Abstract][Full Text] [Related]
8. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.
Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain.
Moon YE; Choi JH; Park HJ; Park JH; Kim JH
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26761032
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin for Central Neuropathic Pain.
Park J; Chung ME
Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29857568
[TBL] [Abstract][Full Text] [Related]
12. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
Sycha T; Kranz G; Auff E; Schnider P
J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain.
Yang KY; Kim MJ; Ju JS; Park SK; Lee CG; Kim ST; Bae YC; Ahn DK
J Dent Res; 2016 Sep; 95(10):1183-90. PubMed ID: 27418174
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin treatment of pain syndromes -an evidence based review.
Safarpour Y; Jabbari B
Toxicon; 2018 Jun; 147():120-128. PubMed ID: 29409817
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
Luvisetto S; Gazerani P; Cianchetti C; Pavone F
Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
[TBL] [Abstract][Full Text] [Related]
18. [Use of botulinum toxin for pain therapy].
Nodera H
Brain Nerve; 2008 May; 60(5):503-8. PubMed ID: 18516972
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Toxin Type A in Dental Medicine.
Muñoz Lora VRM; Del Bel Cury AA; Jabbari B; Lacković Z
J Dent Res; 2019 Dec; 98(13):1450-1457. PubMed ID: 31533008
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions.
Rojewska E; Piotrowska A; Popiolek-Barczyk K; Mika J
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29614835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
